Medical advocacy groups welcomed Johnson & Johnson’s decision not to enforce its patent on a critical tuberculosis medication, allowing its production at much lower prices, after South African authorities opened an investigation into the conglomerate.
South Africa drops probe of J&J after it agrees to lower price of TB drug and withdraws patent
Related Posts
‘Meeting a real-life cyborg was gobsmacking’ says film director
First Born FilmsNeil Harbisson, who sees in black and white, says his antennae lets him “hear” colourFor the past 20 years, self-declared “cyborg artist” Neil Harbisson has provoked debate with…
Raccoon roundworm infections reported in Los Angeles County, health officials warn
A rare parasitic infection known as raccoon roundworm has been confirmed in Los Angeles, according to the Los Angeles County Department of Public Health.Two people in the South Bay area…